drug pricing

Novartis, Amgen and Mallinckrodt used aggressive price hikes to meet sales goals, congressional probe finds
Novartis, Amgen and Mallinckrodt used aggressive price hikes to meet sales goals, congressional probe finds
Fierce Pharma
congress
drug pricing
Novartis
Amgen
Mallinckrodt
Flag link:
Drug costs aren't the main reason US spends so much on healthcare, study finds
Drug costs aren't the main reason US spends so much on healthcare, study finds
Beckers Hospital Review
drug pricing
drug costs
healthcare costs
physicians
Flag link:
Congressional investigation reveals Celgene, Teva plotted to keep drug prices high
Congressional investigation reveals Celgene, Teva plotted to keep drug prices high
RAPS.org
congress
Celgene
Teva Pharmaceutical
Revlimid
Copaxone
drug pricing
Flag link:
CA Governor Looks to Disrupt State’s Generics Market to Promote Affordability
CA Governor Looks to Disrupt State’s Generics Market to Promote Affordability
BioSpace
California
generics
drug pricing
Flag link:
'Uninhibited' price hikes, lobbying and more: Congressional probe gives detailed look into Teva's long run with Copaxone
'Uninhibited' price hikes, lobbying and more: Congressional probe gives detailed look into Teva's long run with Copaxone
Fierce Pharma
Teva Pharmaceutical
Copaxone
congress
MS
drug pricing
competition
Flag link:
Policy makers should ‘set their sights higher’ on U.S. drug pricing regulations, researchers say
Policy makers should ‘set their sights higher’ on U.S. drug pricing regulations, researchers say
MedCity News
drug pricing
JAMA
legislation
Flag link:
GoodRx IPO Shows Low Drug Prices Can Still Mean Big Money
GoodRx IPO Shows Low Drug Prices Can Still Mean Big Money
Forbes
drug pricing
GoodRx
IPOs
Flag link:
Bristol, Amgen, Teva CEOs among execs to testify at House drug pricing hearings next week
Bristol, Amgen, Teva CEOs among execs to testify at House drug pricing hearings next week
Fierce Pharma
drug pricing
regulatory
Celgene
Bristol-Myers Squibb
Teva Pharmaceutical
Amgen
Novartis
Mallinckrodt
AbbVie
US Congress
Flag link:
BIO Chief: “Reckless” Executive Order on Drug Prices Threatens Innovation
BIO Chief: “Reckless” Executive Order on Drug Prices Threatens Innovation
Xconomy
drug pricing
innovation
Donald Trump
executive order
BIO
Flag link:
State treasurers urge Gilead to lower the price of remdesivir and not pursue “unreasonable profits”
State treasurers urge Gilead to lower the price of remdesivir and not pursue “unreasonable profits”
Stat
Gilead Sciences
remdesivir
COVID-19
profits
drug pricing
Flag link:
Combo study of Gilead antiviral, Lilly anti-inflammatory drug positive in Covid-19, but raises pricing jitters
Combo study of Gilead antiviral, Lilly anti-inflammatory drug positive in Covid-19, but raises pricing jitters
MedCity News
Eli Lilly
olumiant
Gilead Sciences
remdesivir
Veklury
drug pricing
COVID-19
Flag link:
Trump Embraces International Reference Pricing in Executive Order
Trump Embraces International Reference Pricing in Executive Order
FDA Law Blog
Donald Trump
drug pricing
executive order
international reference pricing
Flag link:
With election looming, Trump releases major, last-ditch drug pricing order
With election looming, Trump releases major, last-ditch drug pricing order
Stat
Donald Trump
Medicare
executive order
drug pricing
Flag link:
Trump's touting a drug pricing meeting with execs, but PhRMA's 'not aware' of it
Trump's touting a drug pricing meeting with execs, but PhRMA's 'not aware' of it
Fierce Pharma
PhRMA
Donald Trump
drug pricing
Flag link:
AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman
AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman
Fierce Pharma
AbbVie
Imbruvica
Humira
drug pricing
patents
Flag link:
How Covid-19 has enhanced the need for price transparency
How Covid-19 has enhanced the need for price transparency
MedCity News
drug pricing
transparency
pandemic
COVID-19
Flag link:
Federal judge denies Martin Shkreli all but one motion to dismiss monopoly claims in the FTC's Daraprim lawsuit
Federal judge denies Martin Shkreli all but one motion to dismiss monopoly claims in the FTC's Daraprim lawsuit
Endpoints
Martin Shkreli
FTC
Vyera Pharmaceuticals
Daraprim
drug pricing
Flag link:
Five Top Drugmakers Reveal List vs. Net Price Gaps
Five Top Drugmakers Reveal List vs. Net Price Gaps
Drug Channels
Eli Lilly
Janssen
Merck
Novartis
Sanofi
drug pricing
Flag link:
After drug pricing tensions, industry pushes back at Trump's 'Buy American' order
After drug pricing tensions, industry pushes back at Trump's 'Buy American' order
Fierce Pharma
Donald Trump
politics
executive orders
drug pricing
Flag link:
Gilead's COVID med remdesivir is scarce and costly, AGs say, urging feds to sidestep its patents
Gilead's COVID med remdesivir is scarce and costly, AGs say, urging feds to sidestep its patents
Fierce Pharma
Gilead Sciences
remdesivir
COVID-19
FDA
NIH
HHS
drug pricing
Flag link:

Pages